Surbhi Sarna, a former partner at Y Combinator, has raised $30 million to launch Collate, a new startup focused on automating paperwork for life sciences companies using artificial intelligence. The funding round was led by Redpoint, with participation from First Round, Conviction Partners, and Y Combinator, valuing the company at over $100 million. Announced at the J.P. Morgan Healthcare Conference, Collate, which has no customers or commercial product yet, plans to target two or three large life science companies in the coming months. Sarna, who previously sold her startup nVision Medical to Boston Scientific for $275 million, is joined by cofounder Nate Smith and founding chief architect Jigish Patel in this venture.